Meghan Verena Joyce - 04 Aug 2021 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John Saia, as attorney-in-fact for Meghan Verena Joyce
Issuer symbol
GH
Transactions as of
04 Aug 2021
Net transactions value
$0
Form type
4
Filing time
06 Aug 2021, 17:11:19 UTC
Previous filing
20 May 2021
Next filing
20 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Award $0 +3,185 $0.000000 3,185 04 Aug 2021 COMMON STOCK 3,185 $0.000000 Direct F1, F2
transaction GH STOCK OPTION (RIGHT TO BUY) Award $0 +5,350 $0.000000 5,350 04 Aug 2021 COMMON STOCK 5,350 $113.85 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock unit vests as to 25% of the shares subject to such award on August 4, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter.
F2 Not applicable to Restricted Stock Units.
F3 The stock option vests as to 25% of the shares subject to such award on August 4, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of August 4, 2022, during the three-year period thereafter.